CD123 Is Consistently Expressed on <i>NPM1</i>-Mutated AML Cells

CD123 Is Consistently Expressed on <i>NPM1</i>-Mutated AML Cells

<i>NPM1</i>-mutated (<i>NPM1</i>mut) acute myeloid leukemia (AML) comprises about 30% of newly diagnosed AML in adults. Despite notable advances in the treatment of this frequent AML subtype, about 50% of <i>NPM1</i>mut AML patients treated with conventional treat...

Full description

Bibliographic Details
Main Authors: Vincenzo Maria Perriello, Ilaria Gionfriddo, Roberta Rossi, Francesca Milano, Federica Mezzasoma, Andrea Marra, Orietta Spinelli, Alessandro Rambaldi, Ombretta Annibali, Giuseppe Avvisati, Francesco Di Raimondo, Stefano Ascani, Brunangelo Falini, Maria Paola Martelli, Lorenzo Brunetti
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
acute myeloid leukemia (AML)
CD123
NPM1
FLT3
immunotherapy
Online Access:https://www.mdpi.com/2072-6694/13/3/496

Internet

https://www.mdpi.com/2072-6694/13/3/496

Similar Items